[CAPR] Capricor Therapeutics, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2.53 Change: 0.13 (5.42%)
Ext. hours: Change: 0 (0%)

chart CAPR

Refresh chart

Strongest Trends Summary For CAPR

CAPR is in the medium-term up 366% in 2 years. In the long-term down -98% in 19 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Fundamental Ratios
Shares Outstanding EPS-0.86 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 71.59% Sales Growth - Q/Q27.53% P/E-0.81
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-30.88% ROE-115.81% ROI-50.49%
Current Ratio3.37 Quick Ratio Long Term Debt/Equity0.51 Debt Ratio1.03
Gross Margin Operating Margin-149.05% Net Profit Margin-153.3% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities16.48 M Cash From Investing Activities-15.52 M Cash From Operating Activities-2.05 M Gross Profit
Net Profit-3.48 M Operating Profit-3.41 M Total Assets27.47 M Total Current Assets25.42 M
Total Current Liabilities7.55 M Total Debt9.16 M Total Liabilities20.15 M Total Revenue1.79 M
Technical Data
High 52 week6.23 Low 52 week0.32 Last close2.95 Last change-9.23%
RSI14.04 Average true range0.4 Beta0.31 Volume60.2 K
Simple moving average 20 days-36.18% Simple moving average 50 days-23.35% Simple moving average 200 days85.98%
Performance Data
Performance Week-22.77% Performance Month-12.46% Performance Quart404.27% Performance Half478.43%
Performance Year112.23% Performance Year-to-date619.51% Volatility daily15.66% Volatility weekly35.01%
Volatility monthly71.75% Volatility yearly248.54% Relative Volume125.77% Average Volume791.49 K
New High New Low

News

2020-05-26 09:25:10 | Capricor to Participate in Maxim Group's COVID-19 Virtual Conference Series on May 27, 2020

2020-05-14 17:35:09 | Capricor Therapeutics CAPR Reports Q1 Loss, Lags Revenue Estimates

2020-05-14 16:01:10 | Capricor Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

2020-05-13 16:30:10 | Capricor Therapeutics to Present First Quarter 2020 Financial Results and Recent Corporate Update on May 14

2020-05-13 07:00:10 | Capricor Announces Positive Top-Line Final Results from HOPE-2 Study in Patients with Duchenne Muscular Dystrophy Treated with Lead Candidate CAP-1002

2020-05-06 18:44:03 | Capricor CAPR Shares Could Hit $10, Says Analyst

2020-04-30 00:23:20 | Capricor Therapeutics Shares Soar 250% On Successful COVID-19 Treatment News

2020-04-29 09:15:10 | New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002

2020-04-24 07:31:34 | Did You Manage To Avoid Capricor Therapeutics' NASDAQ:CAPR 97% Share Price Wipe Out?

2020-04-13 09:00:10 | Capricor Therapeutics to Host Key Opinion Leader Call on Cardiac Complications of Duchenne Muscular Dystrophy

2020-04-06 16:02:27 | This Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit Upside

2020-04-03 08:00:10 | Capricor Initiates Compassionate Use Program for Severe COVID-19 Patients using CAP-1002, its Novel Cell Therapy

2020-03-24 08:00:10 | Capricor Therapeutics to Host a Key Opinion Leader Call On Why Exosomes are Uniquely Suited for Vaccine Development

2020-03-19 08:30:12 | 4 MedTech Stocks to Scoop Up Amid the Coronavirus Crisis

2020-03-18 16:01:10 | Capricor Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

2020-03-18 14:30:00 | Capricor Therapeutics, Inc. to Host Earnings Call

2020-03-17 08:00:10 | Capricor Therapeutics Announces Strategic Plan for Exosome Platform Technology Products Expansion

2020-03-11 16:30:10 | Capricor Therapeutics to Present Fourth Quarter and Full Year 2019 Financial Results and Recent Corporate Update on March 18

2020-03-10 07:01:44 | Does Capricor Therapeutics, Inc.'s NASDAQ:CAPR CEO Pay Reflect Performance?

2020-02-13 11:30:04 | Is Capricor Therapeutics CAPR Outperforming Other Medical Stocks This Year?

2020-02-03 07:39:12 | Top Ranked Momentum Stocks to Buy for February 3rd

2020-01-28 07:01:12 | Top Ranked Momentum Stocks to Buy for January 28th

2019-12-19 13:14:31 | Capricor Therapeutics Announces Closing of $5.1 Million Offering Priced At-the-Market

2019-12-17 13:52:13 | Capricor Therapeutics Announces Pricing of $5.1 Million Offering Priced At-the-Market

2019-12-11 05:29:20 | We're A Little Worried About Capricor Therapeutics's NASDAQ:CAPR Cash Burn Rate

2019-11-07 17:15:10 | Capricor Therapeutics CAPR Reports Q3 Loss, Lags Revenue Estimates

2019-11-07 16:00:00 | Capricor Therapeutics Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Update

2019-11-01 09:00:00 | Capricor Therapeutics to Present Third Quarter 2019 Financial Results and Recent Corporate Update on November 7

2019-10-27 09:16:10 | How Capricor Therapeutics, Inc. NASDAQ:CAPR Can Impact Your Portfolio Volatility

2019-10-21 09:25:05 | Capricor Therapeutics to Host Key Opinion Leader Call on the Role of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy DMD

2019-10-14 09:35:01 | CHF Solutions System to be Used in JAHVH Study After Final Nod

2019-10-07 12:27:47 | A Look At Benzinga Pro's Most-Searched Tickers For October 7, 2019

2019-10-07 06:30:00 | Capricor Presents Additional Positive Data from Ongoing HOPE-2 Study of CAP-1002 in Duchenne Muscular Dystrophy at World Muscle Society: Data Demonstrates Improved PUL 2.0 Performance at 6 Months

2019-10-04 10:09:02 | Zynex ZYXI Scales 52-Week High: What's Driving the Stock?

2019-10-02 09:15:00 | Capricor to Present Interim Results from the HOPE-2 Trial in a Late Breaking Session of the World Muscle Society and Company to Host Conference Call Monday, October 7 at 5:30 AM PT / 8:30 AM ET

2019-10-01 09:14:01 | Abbott ABT Gets FDA Nod for Spinal Cord Stimulation System

2019-09-26 11:24:03 | Align Gains on Innovation Despite Poor Case Shipment in China

2019-09-26 09:47:01 | Natera NTRA Scales 52-Week High: What's Driving the Stock?

2019-09-25 08:44:12 | Illumina ILMN Inks Deal to Develop Distributable Test Kits

2019-09-24 11:25:03 | FDA Nods to Medtronic's MDT New Age Evolut PRO+ TAVR

2019-09-24 09:20:01 | Insulet Receives FDA Approval for ACE Pump Implementation

2019-09-24 07:42:00 | Capricor Therapeutics shares climb 3.6% on news FDA to meet to discuss DMD treatment

2019-09-24 07:30:00 | Capricor Therapeutics to Meet with FDA to Discuss CAP-1002 to Treat Duchenne Muscular Dystrophy

2019-09-23 09:44:01 | Bruker BRKR Enters Into Alliance With Murdoch University

2019-09-21 08:20:21 | Did You Manage To Avoid Capricor Therapeutics's NASDAQ:CAPR Devastating 92% Share Price Drop?

2019-09-20 09:12:01 | Neogen Forms Partnership With IGS to Enhance Beef Profile

2019-09-19 08:41:12 | Medtronic Receives European Nod for Glucose Monitoring System

2019-09-17 12:29:15 | A Look At Benzinga Pro's Most-Searched Tickers For September 17, 2019

2019-09-17 08:38:12 | Abbott Partners With Sanofi to Upgrade Diabetes Management

2019-09-17 07:00:00 | Capricor Therapeutics to Present Results from the HOPE-2 Trial of CAP-1002 in Duchenne Muscular Dystrophy in a Late Breaking Session of the World Muscle Society